1. Home
  2. JOB vs ELUT Comparison

JOB vs ELUT Comparison

Compare JOB & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GEE Group Inc.

JOB

GEE Group Inc.

HOLD

Current Price

$0.23

Market Cap

20.4M

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.20

Market Cap

23.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOB
ELUT
Founded
1893
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
23.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
JOB
ELUT
Price
$0.23
$1.20
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
175.3K
165.1K
Earning Date
06-02-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.14
EPS
N/A
N/A
Revenue
$96,504,000.00
$24,375,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.50
52 Week High
$0.27
$3.46

Technical Indicators

Market Signals
Indicator
JOB
ELUT
Relative Strength Index (RSI) 50.21 64.61
Support Level $0.19 $0.86
Resistance Level $0.24 $2.05
Average True Range (ATR) 0.02 0.13
MACD -0.00 0.00
Stochastic Oscillator 47.61 74.58

Price Performance

Historical Comparison
JOB
ELUT

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: